{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:23:46Z","timestamp":1791271426680,"version":"4.1.0"},"reference-count":155,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.blre.2013.03.001","type":"journal-article","created":{"date-parts":[[2013,4,28]],"date-time":"2013-04-28T21:15:32Z","timestamp":1367183732000},"page":"119-132","source":"Crossref","is-referenced-by-count":85,"title":["The role of tissue factor pathway inhibitor in atherosclerosis and arterial thrombosis"],"prefix":"10.1016","volume":"27","author":[{"given":"Kristien","family":"Winckers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"ten Cate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman M.","family":"Hackeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2013.03.001_bb0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2013.03.001_bb0010","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1073\/pnas.86.8.2839","article-title":"Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque","volume":"86","author":"Wilcox","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2013.03.001_bb0015","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(96)11189-2","article-title":"Tissue-factor antigen and activity in human coronary atherosclerotic plaques","volume":"349","author":"Ardissino","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2013.03.001_bb0020","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1055\/s-0037-1614932","article-title":"Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients","volume":"79","author":"Falciani","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2013.03.001_bb0025","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1538-7836.2007.02372.x","article-title":"Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study","volume":"5","author":"Morange","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2013.03.001_bb0030","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.99.22.2908","article-title":"Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina","volume":"99","author":"Soejima","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2013.03.001_bb0035","first-page":"675","article-title":"Response to injury and atherogenesis","volume":"86","author":"Ross","year":"1977","journal-title":"Am J Pathol"},{"key":"10.1016\/j.blre.2013.03.001_bb0040","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/ATVBAHA.107.149179","article-title":"Vascular adhesion molecules in atherosclerosis","volume":"27","author":"Galkina","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.blre.2013.03.001_bb0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/path.2518","article-title":"Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis","volume":"218","author":"Sluimer","year":"2009","journal-title":"J Pathol"},{"key":"10.1016\/j.blre.2013.03.001_bb0050","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1056\/NEJM198705283162204","article-title":"Compensatory enlargement of human atherosclerotic coronary arteries","volume":"316","author":"Glagov","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2013.03.001_bb0055","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/10409238809082548","article-title":"Initiation of coagulation by tissue factor","volume":"23","author":"Bach","year":"1988","journal-title":"CRC Crit Rev Biochem"},{"key":"10.1016\/j.blre.2013.03.001_bb0060","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/01.RES.74.1.56","article-title":"A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries","volume":"74","author":"Pawashe","year":"1994","journal-title":"Circ Res"},{"key":"10.1016\/j.blre.2013.03.001_bb0065","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1161\/01.CIR.94.6.1226","article-title":"Identification of active tissue factor in human coronary atheroma","volume":"94","author":"Marmur","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2013.03.001_bb0070","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1160\/TH09-11-0771","article-title":"Tissue factor and thrombosis: the clot starts here","volume":"104","author":"Owens","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2013.03.001_bb0075","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.atherosclerosis.2009.03.014","article-title":"Thrombin generation by intimal tissue factor contributes to thrombus formation on macrophage-rich neointima but not normal intima of hyperlipidemic rabbits","volume":"206","author":"Yamashita","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.blre.2013.03.001_bb0080","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/01.ATV.17.10.2232","article-title":"Tissue factor expression on macrophages in coronary plaques in patients with unstable angina","volume":"17","author":"Kaikita","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.blre.2013.03.001_bb0085","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1055\/s-0038-1650283","article-title":"Tissue factor induces migration of cultured aortic smooth muscle cells","volume":"75","author":"Sato","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2013.03.001_bb0090","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1056\/NEJMra1011670","article-title":"The hemostatic system as a modulator of atherosclerosis","volume":"364","author":"Borissoff","year":"2011","journal-title":"N Engl J Med"},{"issue":"Suppl. 2","key":"10.1016\/j.blre.2013.03.001_bb0095","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.thromres.2012.02.028","article-title":"Tissue factor-driven thrombin generation and inflammation in atherosclerosis","volume":"129","author":"ten Cate","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2013.03.001_bb0100","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1161\/01.ATV.0000202028.62414.3c","article-title":"Atherosclerosis in mice is not affected by a reduction in tissue factor expression","volume":"26","author":"Tilley","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.blre.2013.03.001_bb0105","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIRCULATIONAHA.108.780734","article-title":"Presence of older thrombus is an independent predictor of long-term mortality in patients with ST-elevation myocardial infarction treated with thrombus aspiration during primary percutaneous coronary intervention","volume":"118","author":"Kramer","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2013.03.001_bb0110","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1055\/s-0037-1615914","article-title":"Regulation of the procoagulant response to arterial injury","volume":"82","author":"Taubman","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2013.03.001_bb0115","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1073\/pnas.89.6.2317","article-title":"Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells","volume":"89","author":"Gasic","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2013.03.001_bb0120","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/cvr\/cvp066","article-title":"Is thrombin a key player in the \u2018coagulation-atherogenesis\u2019 maze?","volume":"82","author":"Borissoff","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.blre.2013.03.001_bb0125","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1073\/pnas.72.1.131","article-title":"Mitogenic activity of blood components. I. Thrombin and prothrombin","volume":"72","author":"Chen","year":"1975","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2013.03.001_bb0130","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1073\/pnas.71.4.1207","article-title":"A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro","volume":"71","author":"Ross","year":"1974","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2013.03.001_bb0135","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1172\/JCI115613","article-title":"Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty","volume":"89","author":"Jawien","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2013.03.001_bb0140","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/CIRCULATIONAHA.109.907121","article-title":"Early atherosclerosis exhibits an enhanced procoagulant state","volume":"122","author":"Borissoff","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2013.03.001_bb0145","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1161\/01.CIR.89.3.1262","article-title":"Specific factor Xa inhibition reduces restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits","volume":"89","author":"Ragosta","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2013.03.001_bb0150","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.CIR.84.1.232","article-title":"Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits","volume":"84","author":"Sarembock","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2013.03.001_bb0155","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/j.1538-7836.2012.04782.x","article-title":"The impact of blood coagulability on atherosclerosis and cardiovascular disease","volume":"10","author":"Loeffen","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2013.03.001_bb0160","first-page":"551","article-title":"Heterogeneity of plasma tissue factor pathway inhibitor","volume":"5","author":"Broze","year":"1994","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.blre.2013.03.001_bb0165","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1016\/S0021-9258(18)68737-X","article-title":"Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains","volume":"263","author":"Wun","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2013.03.001_bb0170","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood.V71.2.335.335","article-title":"The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action","volume":"71","author":"Broze","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.03.001_bb0175","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/338518a0","article-title":"Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor","volume":"338","author":"Girard","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.blre.2013.03.001_bb0180","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1073\/pnas.0504240103","article-title":"Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor","volume":"103","author":"Hackeng","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2013.03.001_bb0185","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1182\/blood-2009-10-246686","article-title":"The Kunitz-3 domain of TFPI-alpha is required for protein S-dependent enhancement of factor Xa inhibition","volume":"116","author":"Ndonwi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.03.001_bb0190","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1172\/JCI117855","article-title":"The carboxy terminus of tissue factor pathway inhibitor is required for interacting with hepatoma cells in vitro and in vivo","volume":"95","author":"Warshawsky","year":"1995","journal-title":"J Clin Invest"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2013.03.001_bb0195","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.thromres.2010.01.038","article-title":"Alternatively spliced isoforms of tissue factor pathway inhibitor","volume":"125","author":"Maroney","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2013.03.001_bb0200","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2741\/3926","article-title":"Tissue factor pathway inhibitor: structure-function","volume":"17","author":"Broze","year":"2012","journal-title":"Front Biosci"},{"key":"10.1016\/j.blre.2013.03.001_bb0205","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1161\/01.RES.83.12.1264","article-title":"Expression of tissue factor pathway inhibitor in vascular smooth muscle cells and its regulation by growth factors","volume":"83","author":"Caplice","year":"1998","journal-title":"Circ Res"},{"key":"10.1016\/j.blre.2013.03.001_bb0210","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.transci.2007.12.001","article-title":"Expression of tissue factor pathway inhibitor by endothelial cells and platelets","volume":"38","author":"Maroney","year":"2008","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.blre.2013.03.001_bb0215","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1084\/jem.179.6.1847","article-title":"Simultaneous expression of tissue factor and tissue factor pathway inhibitor by human monocytes. A potential mechanism for localized control of blood coagulation","volume":"179","author":"McGee","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.blre.2013.03.001_bb0220","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1055\/s-0038-1651613","article-title":"Distribution of tissue factor pathway inhibitor in normal and malignant human tissues","volume":"69","author":"Werling","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2013.03.001_bb0225","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/01.ATV.19.2.309","article-title":"Tissue factor pathway inhibitor is expressed by human monocyte-derived macrophages: relationship to tissue factor induction by cholesterol and oxidized LDL","volume":"19","author":"Petit","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.blre.2013.03.001_bb0230","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1161\/01.ATV.15.11.2055","article-title":"Thrombin induces the redistribution and acute release of tissue factor pathway inhibitor from specific granules within human endothelial cells in culture","volume":"15","author":"Lupu","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.blre.2013.03.001_bb0235","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1161\/01.ATV.19.9.2251","article-title":"Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture","volume":"19","author":"Lupu","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.blre.2013.03.001_bb0240","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1182\/blood.V78.2.394.394","article-title":"Purification and properties of heparin-releasable lipoprotein-associated coagulation inhibitor","volume":"78","author":"Novotny","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.03.001_bb0245","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0049-3848(88)90340-4","article-title":"Heparin induces release of extrinsic coagulation pathway inhibitor (EPI)","volume":"50","author":"Sandset","year":"1988","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2013.03.001_bb0250","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/path.1871","article-title":"Tissue factor pathway inhibitor: structure, biology and involvement in disease","volume":"208","author":"Lwaleed","year":"2006","journal-title":"J Pathol"},{"key":"10.1016\/j.blre.2013.03.001_bb0255","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1182\/blood.V72.6.2020.2020","article-title":"Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor","volume":"72","author":"Novotny","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.03.001_bb0260","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1182\/blood-2006-07-037283","article-title":"Active tissue factor pathway inhibitor is expressed on the surface of coated platelets","volume":"109","author":"Maroney","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.03.001_bb0265","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1074\/jbc.273.8.4378","article-title":"Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor","volume":"273","author":"Baugh","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2013.03.001_bb0270","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1182\/blood.V79.8.2004.2004","article-title":"Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa","volume":"79","author":"Wesselschmidt","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.03.001_bb0275","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1161\/01.ATV.19.10.2563","article-title":"Structural requirements for TFPI-mediated inhibition of neointimal thickening after balloon injury in the rat","volume":"19","author":"Han","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.blre.2013.03.001_bb0280","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1182\/blood.V90.3.944","article-title":"Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice","volume":"90","author":"Huang","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.03.001_bb0285","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1172\/JCI5678","article-title":"Factor VII deficiency rescues the intrauterine lethality in mice associated with a tissue factor pathway inhibitor deficit","volume":"103","author":"Chan","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2013.03.001_bb0290","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.atherosclerosis.2009.04.024","article-title":"Tissue factor pathway inhibitor, vascular risk factors and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis","volume":"207","author":"Mitchell","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.blre.2013.03.001_bb0295","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.thromres.2010.01.045","article-title":"Mechanisms of estrogen-induced venous thromboembolism","volume":"126","author":"Tchaikovski","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2013.03.001_bb0300","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/s-0037-1614443","article-title":"Low levels of heparin-releasable tissue factor pathway inhibitor in young patients with thrombosis","volume":"81","author":"Ariens","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2013.03.001_bb0305","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1182\/blood-2002-10-3188","article-title":"Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis","volume":"101","author":"Dahm","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.03.001_bb0310","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1073\/pnas.1119858109","article-title":"Absence of hematopoietic tissue factor pathway inhibitor mitigates bleeding in mice with hemophilia","volume":"109","author":"Maroney","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2013.03.001_bb0315","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1055\/s-0030-1265293","article-title":"Tissue factor and tissue factor pathway inhibitor as key regulators of global hemostasis: measurement of their levels in coagulation assays","volume":"36","author":"Kasthuri","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.blre.2013.03.001_bb0320","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1538-7836.2010.03743.x","article-title":"Thrombin generation-based assays to measure the activity of the TFPI-protein S pathway in plasma from normal and protein S-deficient individuals","volume":"8","author":"Maurissen","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2013.03.001_bb0325","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0049-3848(98)00147-9","article-title":"Plasma tissue factor pathway inhibitor and tissue factor antigen levels after administration of heparin in patients with angina pectoris","volume":"93","author":"Soejima","year":"1999","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2013.03.001_bb0330","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1161\/01.ATV.20.5.1362","article-title":"Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels","volume":"20","author":"Crawley","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.blre.2013.03.001_bb0335","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9150(98)00077-X","article-title":"Expression of tissue factor in the rabbit aorta after balloon injury","volume":"139","author":"Hatakeyama","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.blre.2013.03.001_bb0340","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1172\/JCI116452","article-title":"Tissue factor is rapidly induced in arterial smooth muscle after balloon injury","volume":"91","author":"Marmur","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2013.03.001_bb0345","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/(SICI)1096-9896(199906)188:2<180::AID-PATH338>3.0.CO;2-Q","article-title":"Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis","volume":"188","author":"Kaikita","year":"1999","journal-title":"J Pathol"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2013.03.001_bb0350","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.thromres.2010.01.039","article-title":"Interdependent biological systems, multi-functional molecules: the evolving role of tissue factor pathway inhibitor beyond anti-coagulation","volume":"125","author":"Holroyd","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2013.03.001_bb0355","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/01.CIR.102.1.113","article-title":"Endogenous tissue factor pathway inhibitor modulates thrombus formation in an in vivo model of rabbit carotid artery stenosis and endothelial injury","volume":"102","author":"Ragni","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2013.03.001_bb0360","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1161\/hc2501.092492","article-title":"Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in mice","volume":"103","author":"Westrick","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2013.03.001_bb0365","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/S0735-1097(00)01018-4","article-title":"Inhibition of tissue factor reduces thrombus formation and intimal hyperplasia after porcine coronary angioplasty","volume":"36","author":"Roque","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.blre.2013.03.001_bb0370","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/01.ATV.19.9.2263","article-title":"Tissue factor pathway inhibitor attenuates procoagulant activity and upregulation of tissue factor at the site of balloon-induced arterial injury in pigs","volume":"19","author":"St Pierre","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.blre.2013.03.001_bb0375","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1182\/blood-2003-04-1148","article-title":"Inhibition of restenosis by tissue factor pathway inhibitor: in vivo and in vitro evidence for suppressed monocyte chemoattraction and reduced gelatinolytic activity","volume":"103","author":"Kopp","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.03.001_bb0380","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1161\/01.RES.84.12.1446","article-title":"Adenovirus-mediated local expression of human tissue factor pathway inhibitor eliminates shear stress-induced recurrent thrombosis in the injured carotid artery of the rabbit","volume":"84","author":"Nishida","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.blre.2013.03.001_bb0385","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/01.CIR.101.3.289","article-title":"Thromboresistance of balloon-injured porcine carotid arteries after local gene transfer of human tissue factor pathway inhibitor","volume":"101","author":"Zoldhelyi","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2013.03.001_bb0390","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0049-3848(99)00032-8","article-title":"Overexpression of tissue factor pathway inhibitor in aortic smooth muscle cells inhibits cell migration induced by tissue factor\/factor VIIa complex","volume":"94","author":"Sato","year":"1999","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2013.03.001_bb0395","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1055\/s-0038-1657700","article-title":"Tissue factor pathway inhibitor inhibits aortic smooth muscle cell migration induced by tissue factor\/factor VIIa complex","volume":"78","author":"Sato","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2013.03.001_bb0400","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/01.CIR.96.2.646","article-title":"Inhibition of tissue factor-mediated coagulation markedly attenuates stenosis after balloon-induced arterial injury in minipigs","volume":"96","author":"Oltrona","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2013.03.001_bb0405","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1161\/01.CIR.92.10.3041","article-title":"Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model","volume":"92","author":"Jang","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2013.03.001_bb0410","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1055\/s-0037-1615237","article-title":"Fibrin-rich and platelet-rich thrombus formation on neointima: recombinant tissue factor pathway inhibitor prevents fibrin formation and neointimal development following repeated balloon injury of rabbit aorta","volume":"80","author":"Asada","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2013.03.001_bb0415","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1067\/mva.2001.113307","article-title":"Topically applied tissue factor pathway inhibitor reduced intimal thickness of small arterial autografts in rabbits","volume":"34","author":"Sun","year":"2001","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.blre.2013.03.001_bb0420","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/01.CIR.103.4.570","article-title":"Combination of a brief irrigation with tissue factor pathway inhibitor (TFPI) and adenovirus-mediated local TFPI gene transfer additively reduces neointima formation in balloon-injured rabbit carotid arteries","volume":"103","author":"Atsuchi","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2013.03.001_bb0425","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1073\/pnas.061004098","article-title":"Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries","volume":"98","author":"Zoldhelyi","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2013.03.001_bb0430","doi-asserted-by":"crossref","first-page":"12241","DOI":"10.1074\/jbc.M010395200","article-title":"Tissue factor pathway inhibitor inhibits endothelial cell proliferation via association with the very low density lipoprotein receptor","volume":"276","author":"Hembrough","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2013.03.001_bb0435","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/CIRCRESAHA.109.195016","article-title":"Vascular-directed tissue factor pathway inhibitor overexpression regulates plasma cholesterol and reduces atherosclerotic plaque development","volume":"105","author":"Pan","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.blre.2013.03.001_bb0440","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1182\/blood.V90.5.1883","article-title":"A novel degradation pathway of tissue factor pathway inhibitor: incorporation into fibrin clot and degradation by thrombin","volume":"90","author":"Ohkura","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.03.001_bb0445","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1055\/s-0037-1615224","article-title":"Proteolysis of tissue factor pathway inhibitor (TFPI) by plasmin: effect on TFPI activity","volume":"80","author":"Li","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2013.03.001_bb0450","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-0037-1615187","article-title":"Factor Xa cleavage of tissue factor pathway inhibitor is associated with loss of anticoagulant activity","volume":"80","author":"Salemink","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2013.03.001_bb0455","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.1182\/blood-2010-10-316257","article-title":"Activated protein C up-regulates procoagulant tissue factor activity on endothelial cells by shedding the TFPI Kunitz 1 domain","volume":"117","author":"Schuepbach","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.03.001_bb0460","doi-asserted-by":"crossref","first-page":"27123","DOI":"10.1016\/S0021-9258(19)61488-2","article-title":"Matrix metalloproteinases cleave tissue factor pathway inhibitor. Effects on coagulation","volume":"275","author":"Belaaouaj","year":"2000","journal-title":"J Biol Chem."},{"key":"10.1016\/j.blre.2013.03.001_bb0465","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1042\/bj20020696","article-title":"Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8","volume":"367","author":"Cunningham","year":"2002","journal-title":"Biochem J"},{"key":"10.1016\/j.blre.2013.03.001_bb0470","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1111\/j.1742-4658.2007.05833.x","article-title":"Tissue factor pathway inhibitor is highly susceptible to chymase-mediated proteolysis","volume":"274","author":"Hamuro","year":"2007","journal-title":"FEBS J"},{"key":"10.1016\/j.blre.2013.03.001_bb0475","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/ATVBAHA.111.238394","article-title":"Factor VII-activating protease promotes the proteolysis and inhibition of tissue factor pathway inhibitor","volume":"32","author":"Kanse","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.blre.2013.03.001_bb0480","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1055\/s-0038-1648489","article-title":"Effect of leukocyte proteinases on tissue factor pathway inhibitor","volume":"67","author":"Petersen","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2013.03.001_bb0485","first-page":"291","article-title":"Tissue factor pathway inhibitor expression in atherosclerosis","volume":"77","author":"Drew","year":"1997","journal-title":"Lab Invest"},{"key":"10.1016\/j.blre.2013.03.001_bb0490","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1182\/blood.V79.12.3219.3219","article-title":"Expression of tissue factor pathway inhibitor by cultured endothelial cells in response to inflammatory mediators","volume":"79","author":"Ameri","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.03.001_bb0495","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1161\/01.CIR.98.11.1051","article-title":"Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity","volume":"98","author":"Caplice","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2013.03.001_bb0500","first-page":"366","article-title":"TFPI antigen and activity levels in patients with asymptomatic atherosclerosis and target organ acute and chronic complications","volume":"24","author":"Novo","year":"2005","journal-title":"Int Angiol"},{"key":"10.1016\/j.blre.2013.03.001_bb0505","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-0037-1615152","article-title":"Correlates of antithrombin, protein C, protein S, and TFPI in a healthy elderly cohort","volume":"80","author":"Sakkinen","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2013.03.001_bb0510","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.atherosclerosis.2004.05.017","article-title":"Potential of free-form TFPI and PAI-1 to be useful markers of early atherosclerosis in a Japanese general population (the Suita Study): association with the intimal\u2013medial thickness of carotid arteries","volume":"176","author":"Sakata","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.blre.2013.03.001_bb0515","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.numecd.2008.10.003","article-title":"Markers of inflammation, thrombosis and endothelial activation correlate with carotid IMT regression in stable coronary disease after atorvastatin treatment","volume":"19","author":"Baldassarre","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.blre.2013.03.001_bb0520","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.numecd.2007.01.008","article-title":"E-selectin and TFPI are associated with carotid intima\u2013media thickness in stable IHD patients: the baseline findings of the MIAMI study","volume":"18","author":"Porta","year":"2008","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.blre.2013.03.001_bb0525","first-page":"937","article-title":"Tissue factor pathway inhibitor, natural coagulation inhibitors and hemostatic activation markers in patients with acute coronary syndromes","volume":"26","author":"Al-Nozha","year":"2005","journal-title":"Saudi Med J"},{"key":"10.1016\/j.blre.2013.03.001_bb0530","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1160\/TH03-11-0674","article-title":"Coagulation activation in young survivors of myocardial infarction (MI)\u2014a population-based case-control study","volume":"92","author":"Brodin","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2013.03.001_bb0535","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1046\/j.1365-2141.1998.00804.x","article-title":"Monocyte tissue factor-like activity in post myocardial infarction patients","volume":"102","author":"Freeburn","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2013.03.001_bb0540","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0049-3848(02)00331-6","article-title":"Observation on tissue factor pathway and some other coagulation parameters during the onset of acute cerebrocardiac thrombotic diseases","volume":"107","author":"He","year":"2002","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2013.03.001_bb0545","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/(SICI)1096-8652(199707)55:4<183::AID-AJH3>3.0.CO;2-O","article-title":"Increased tissue factor pathway inhibitor in patients with acute myocardial infarction","volume":"55","author":"Kamikura","year":"1997","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2013.03.001_bb0550","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/01.ATV.20.1.251","article-title":"Intravascular free tissue factor pathway inhibitor is inversely correlated with HDL cholesterol and postheparin lipoprotein lipase but proportional to apolipoprotein A-II","volume":"20","author":"Kawaguchi","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.blre.2013.03.001_bb0555","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1055\/s-0038-1642509","article-title":"Relationship of tissue factor pathway inhibitor activity to plasma lipoproteins and myocardial infarction at a young age","volume":"71","author":"Moor","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2013.03.001_bb0560","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1161\/01.CIR.0000120705.55512.EC","article-title":"Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study","volume":"109","author":"Morange","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2013.03.001_bb0565","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1055\/s-0037-1616051","article-title":"Imbalance of plasminogen activator inhibitor-I\/tissue plasminogen activator and tissue factor\/tissue factor pathway inhibitor in young Japanese men with myocardial infarction","volume":"86","author":"Saigo","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2013.03.001_bb0570","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1111\/j.1538-7836.2011.04497.x","article-title":"Increased tissue factor pathway inhibitor activity is associated with myocardial infarction in young women: results from the RATIO study","volume":"9","author":"Winckers","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2013.03.001_bb0575","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2141.1989.tb07721.x","article-title":"Factor VII and extrinsic pathway inhibitor in acute coronary disease","volume":"72","author":"Sandset","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2013.03.001_bb0580","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1538-7836.2009.03712.x","article-title":"Hereditary and acquired protein S deficiencies are associated with low TFPI levels in plasma","volume":"8","author":"Castoldi","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2013.03.001_bb0585","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1161\/01.CIR.0000105900.21445.3D","article-title":"Involvement of tissue factor pathway inhibitor in the coronary circulation of patients with acute coronary syndromes","volume":"108","author":"Golino","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2013.03.001_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2012.02.044","article-title":"Lower tissue factor inhibition in patients with ST segment elevation than in patients with non ST elevation acute myocardial infarction","author":"Figueras","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2013.03.001_bb0595","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.thromres.2010.07.002","article-title":"Plasma factor and inhibitor composition contributes to thrombin generation dynamics in patients with acute or previous cerebrovascular events","volume":"126","author":"Gissel","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2013.03.001_bb0600","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1055\/s-0038-1649880","article-title":"Decreased plasma tissue factor pathway inhibitor activity in ischemic stroke patients","volume":"74","author":"Abumiya","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2013.03.001_bb0605","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/01.mbc.0000245294.41774.06","article-title":"The tissue factor pathway in ischemic stroke","volume":"17","author":"Adams","year":"2006","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.blre.2013.03.001_bb0610","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1161\/STROKEAHA.111.643072","article-title":"Tissue factor pathway inhibitor, activated protein C resistance, and risk of ischemic stroke due to postmenopausal hormone therapy","volume":"43","author":"Rossouw","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.blre.2013.03.001_bb0615","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/brain\/awg040","article-title":"Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis","volume":"126","author":"Hassan","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.blre.2013.03.001_bb0620","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1212\/WNL.0b013e318246d6b7","article-title":"Levels of heparin-releasable TFPI are increased in first-ever lacunar stroke patients","volume":"78","author":"Knottnerus","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.blre.2013.03.001_bb0625","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/01.STR.0000169924.60783.d4","article-title":"Markers of endothelial and hemostatic activation and progression of cerebral white matter hyperintensities: longitudinal results of the Austrian Stroke Prevention Study","volume":"36","author":"Markus","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.blre.2013.03.001_bb0630","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0021-9150(99)00444-X","article-title":"Differences in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controls","volume":"152","author":"Blann","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.blre.2013.03.001_bb0635","first-page":"296","article-title":"Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study","volume":"27","author":"Gosk-Bierska","year":"2008","journal-title":"Int Angiol"},{"key":"10.1016\/j.blre.2013.03.001_bb0640","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1021\/bi00220a018","article-title":"Intron\u2013exon organization of the human gene coding for the lipoprotein-associated coagulation inhibitor: the factor Xa dependent inhibitor of the extrinsic pathway of coagulation","volume":"30","author":"van der Logt","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.blre.2013.03.001_bb0645","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1161\/01.ATV.0000166602.04711.2e","article-title":"A locus on chromosome 2 influences levels of tissue factor pathway inhibitor: results from the GAIT study","volume":"25","author":"Almasy","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.blre.2013.03.001_bb0650","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbrc.2010.05.078","article-title":"Functional characterization of polymorphisms in the human TFPI gene","volume":"397","author":"Skretting","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.blre.2013.03.001_bb0655","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1055\/s-0037-1614003","article-title":"A new T-287C polymorphism in the 5\u2032 regulatory region of the tissue factor pathway inhibitor gene. Association study of the T-287C and C-399T polymorphisms with coronary artery disease and plasma TFPI levels","volume":"84","author":"Moatti","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2013.03.001_bb0660","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00001721-200106000-00013","article-title":"Polymorphisms of the tissue factor pathway inhibitor gene and the risk of restenosis after coronary angioplasty","volume":"12","author":"Moatti","year":"2001","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.blre.2013.03.001_bb0665","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1161\/01.ATV.19.4.862","article-title":"Polymorphisms of the tissue factor pathway inhibitor (TFPI) gene in patients with acute coronary syndromes and in healthy subjects: impact of the V264M substitution on plasma levels of TFPI","volume":"19","author":"Moatti","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.blre.2013.03.001_bb0670","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/MBC.0b013e3282dde994","article-title":"Polymorphisms in the tissue factor pathway inhibitor gene are not associated with ischaemic stroke","volume":"18","author":"Sayer","year":"2007","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.blre.2013.03.001_bb0675","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0049-3848(87)90154-X","article-title":"Inhibition of the tissue factor-factor VII complex: involvement of factor Xa and lipoproteins","volume":"46","author":"Hubbard","year":"1987","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2013.03.001_bb0680","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00001721-199106000-00004","article-title":"Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): levels in the normal population and relation to cholesterol","volume":"2","author":"Sandset","year":"1991","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.blre.2013.03.001_bb0685","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1182\/blood.V78.2.387.387","article-title":"Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples","volume":"78","author":"Novotny","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.03.001_bb0690","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/01.ATV.14.2.223","article-title":"Tissue-factor pathway inhibitor and lipoproteins. Evidence for association with and regulation by LDL in human plasma","volume":"14","author":"Hansen","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.blre.2013.03.001_bb0695","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/01.ATV.11.1.138","article-title":"Treatment with hydroxymethylglutaryl-coenzyme A reductase inhibitors in hypercholesterolemia induces changes in the components of the extrinsic coagulation system","volume":"11","author":"Sandset","year":"1991","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.blre.2013.03.001_bb0700","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.ATV.14.3.483","article-title":"Response of plasma tissue factor pathway inhibitor to diet-induced hypercholesterolemia in crab-eating monkeys","volume":"14","author":"Abumiya","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.blre.2013.03.001_bb0705","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1016\/j.atherosclerosis.2006.10.012","article-title":"Dyslipidemia shifts the tissue factor\/tissue factor pathway inhibitor balance toward increased thrombogenicity in atherosclerotic plaques: evidence for a corrective effect of statins","volume":"195","author":"Zawadzki","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.blre.2013.03.001_bb0710","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1172\/JCI58969","article-title":"Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin","volume":"122","author":"Owens","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2013.03.001_bb0715","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/01.ATV.0000051384.43104.FC","article-title":"Endothelial dysfunction: a marker of atherosclerotic risk","volume":"23","author":"Bonetti","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.blre.2013.03.001_bb0720","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/CIRCULATIONAHA.106.652859","article-title":"Endothelial function and dysfunction: testing and clinical relevance","volume":"115","author":"Deanfield","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2013.03.001_bb0725","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1536\/jhj.43.117","article-title":"Relationships between brachial artery flow mediated dilation and carotid artery intima\u2013media thickness in patients with suspected coronary artery disease","volume":"43","author":"Furomoto","year":"2002","journal-title":"Jpn Heart J"},{"key":"10.1016\/j.blre.2013.03.001_bb0730","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1161\/ATVBAHA.110.221911","article-title":"Tissue factor pathway inhibitor: a new link among arterial stiffness, pulse pressure, and coagulation in postmenopausal women","volume":"31","author":"Regnault","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.blre.2013.03.001_bb0735","first-page":"125","article-title":"Eprosartan effect on fibrinolytic\/hemostatic variables in arterial hypertension: a comparative study to losartan","volume":"30","author":"Makris","year":"2004","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.blre.2013.03.001_bb0740","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0895-7061(00)00262-4","article-title":"Fibrinolytic\/hemostatic variables in arterial hypertension: response to treatment with irbesartan or atenolol","volume":"13","author":"Makris","year":"2000","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.blre.2013.03.001_bb0745","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198610163151602","article-title":"Platelet activation in unstable coronary disease","volume":"315","author":"Fitzgerald","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2013.03.001_bb0750","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0002-8703(97)70132-7","article-title":"Increased plasma tissue factor levels in acute myocardial infarction","volume":"134","author":"Suefuji","year":"1997","journal-title":"Am Heart J"},{"key":"10.1016\/j.blre.2013.03.001_bb0755","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0002-9149(97)00801-1","article-title":"Comparison of plasma tissue factor levels in unstable and stable angina pectoris","volume":"81","author":"Misumi","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.blre.2013.03.001_bb0760","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00019501-200505000-00007","article-title":"Determinants of endothelial dysfunction and carotid intima-media thickness in combined hyperlipidemia","volume":"16","author":"Sebestjen","year":"2005","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.blre.2013.03.001_bb0765","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2003-38328","article-title":"Basic mechanisms of hemostasis","volume":"3","author":"Sere","year":"2003","journal-title":"Semin Vasc Med"},{"key":"10.1016\/j.blre.2013.03.001_bb0770","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nrd1548","article-title":"Molecular, cellular and functional imaging of atherothrombosis","volume":"3","author":"Choudhury","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.blre.2013.03.001_bb9000","doi-asserted-by":"crossref","first-page":"31715","DOI":"10.1074\/jbc.M006595200","article-title":"Tissue factor pathway inhibitor binds to platelet thrombospondin-1","volume":"275","author":"Mast","year":"2000","journal-title":"J Biol Chem"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X13000167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X13000167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T23:16:52Z","timestamp":1644880612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X13000167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":155,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0268960X13000167"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2013.03.001","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}